Oppenheimer analyst Steven Lichtman downgraded Medtronic, Inc. (NYSE: MDT) from Outperform to Perform with a price target of $85.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE